-+ 0.00%
-+ 0.00%
-+ 0.00%

Protalix BioTherapeutics Q2 Sales $15.658M Beat $13.546M Estimate

Benzinga·08/14/2025 10:51:53
Listen to the news
Protalix BioTherapeutics (AMEX:PLX) reported quarterly sales of $15.658 million which beat the analyst consensus estimate of $13.546 million by 15.59 percent. This is a 16.21 percent increase over sales of $13.474 million the same period last year.